Association of heart failure in homozygous β-thalassemia with the major histocompatibility complex

Circulation

Volumn 100, Issue 20, 1999, Pages 2074-2078

  Kremastinos, Dimitrios T ^a,b   Flevari, Panagiota ^a   Spyropoulou, Maria ^a   Vrettou, Helen ^a   Tsiapras, Dimitrios ^a   Stavropoulos Giokas, Catherine G ^a  

^a IASO GENERAL HOSPITAL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cardiomyopathy; Genetics; Heart failure; Immune system

Indexed keywords

DNA; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; HEART FAILURE; HUMAN; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032732695     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.20.2074     Document Type: Article

References (41)

1. Dwyer J, Wood C, McNamara J, Williams A, Andiman W, Rink L, O'Connor T, Pearson H. Abnormalities in the immune system of children with β-thalassemia major. Clin Exp Immunol. 1987;68:621-629.
2. Uguccioni M, Meliconi R, Nesci S, Lucarelli G, Ceska M, Gasbarrini G, Facchini A. Elevated interleukin-8 serum concentrations in β-thalassemia and graft-versus-host disease. Blood. 1993;81:2252-2256.
3. Lombardi G, Matera R, Minervini MM, Cascavilla N, D'Arcangelo P, Carotenuto M, Di Giorgio G, Musto P. Serum levels of cytokines and soluble antigens in polytransfused patients with β-thalassemia major: relationship to immune status. Haematologica. 1994;79:406-412.
4. Zurlo MG, De Stefano P, Borgna-Pignatti C. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27-30.
5. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in β-thalassemia major: a cause of heart failure Circulation. 1995;91:66-71.
6. Kishimoto C, Abelmank WH. In vivo significance of T cells in the development of coxsackievirus B3 myocarditis in mice: immature but antigen-specific T cells aggravate cardiac injury. Circ Res 1990;67: 589-598.
7. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res. 1994;74:182-188.
8. Shabetai R. Myocarditis and dilated cardiomyopathy: twins or distant relatives? Cardiology. 1989;76:332-337.
9. Herskowitz A. Concepts of autoimmunity applied to idiopathic cardiomyopathy. J Am Coll Cardiol. 1993;22:1378-1384. Editorial.
10. Caforio ALP. Role of autoimmunity in dilated cardiomyopathy. Br Heart J. 1994;72:830-534.
11. Neumann DA. Autoimmunity and idiopathic dilated cardiomyopathy. Mayo Clin Proc. 1994;69:193-195.
12. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R. Organspecific autoimmunity: a 1986 overview. Immunol Rev. 1986;94: 137-159.
13. Limas C, Limas CJ, Boudoulas H, Bair R, Graber H, Sparks L, Wooley CF. Anti-β-receptor antibodies in familial cardiomyopathy: correlation with HLA-DR and HLA-DQ gene polymorphisms. Am Heart J. 1994; 127:382-386.
14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichen N, Sahn D, Schnittger I, Silverman NH, Tajih AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Quantitation of Two-Dimensional Echocardiography. J Am Soc Echocardiogr. 1989;2: 358-367.
15. Sahn DJ, De Maria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58: 1072-1083.
16. Terasaki Paul I. Histocompatibility Testing 1980. Los Angeles, Calif: UCLA Tissue Typing Laboratory; 1980.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215.
18. Saiki RK, Gelfrand DH, Stoffel S, Scharf SJ, Higuchi G, Hom T, Mulis KB, Erlich HA. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487-491.
19. Technical Handbook. St-Malo/Paris, France: XIIth International Histocompatibility Workshop; June 3-12, 1996.
20. Nevinny-Stickel C, Bettinoti MD, Andreas A, Hinzpeter M, Muhlegger K, Schmilz G, Albert ED. Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2′-3′-dideoxyuridinetriphosphate-labeled oligonucleotide probes. Hum Immunol. 1991;31:7-13.
21. Bura M, Roberts W. Iron in the heart: etiology and clinical significance. Am J Med. 1971;51:209-221.
22. Schafer A, Cheron R, Dluhy R, Cooper B, Bunn F. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med. 1981; 304:319-324.
23. Jessup M, Manno CS. Diagnosis and management of iron-induced heart disease in Cooley's anemia. Ann N Y Acad Sci. 1998;850:242-250.
24. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe refractory anemia with hemochromatosis. Circulation. 1964;30:698-705.
25. Lymberi P, Aessopos A, Karageorga M, Hadzigianni D, Loukopoulos D, Kaklamanis P. Increased IgA natural autoantibody activity in sera of patients with homozygous thalassemia. Autoimmunity. 1990;8:81-82.
26. Abbas AK, Lichtman AH, Pober JS. Self-tolerance and autoimmunity. In: Abbas AK, Lichtman AH, Pober JS, eds. Cellular and Molecular Immunology. Philadelphia, Pa: WB Saunders Co: 1997:406-422.
27. Economou-Petersen E, Aessopos A, Kladi A, Flevari P, Karabatsos F, Fragodimitri C, Nicolaidis, P, Vrettou H, Vassilopoulos D, Karagiorga-Lagana M, Kremastinos DT, Petersen M. Apolipoprotein E ε4 allele as a genetic risk factor for left ventricular failure in homozygous β-thalassemia. Blood. 1998;92:3455-3459.
28. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet. 1996;14:55-61.
29. Hiraoka Y, Kishimoto C, Takada H, Kurokawa M, Ochiaai H, Shiraki K, Sasayama S. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc Res. 1993;27: 957-961.
30. Suzuki H, Matsumori A, Matoba Y, Kyu BS, Tanaka A, Fujita J, Sasayama S. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis: an SH-dependent reduction of its expression and myocardial injury. J Clin Invest. 1993;91:2727-2733.
31. Muir P, Nicholson F, Tilzey AJ, Signy M, English TA, Banatvala JE. Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet. 1989;1:804-807.
32. O'Connell JB, Mason JW. Immunosuppressive therapy in experimental and clinical myocarditis. Pathol Immunopathol Res. 1988;7:292-304.
33. Ansari AA, Wang YC, Danner DJ, Gravanis MB, Mayne A, Neckelmann N, Sell KW, Herskowitz A. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol. 1991;139:337-354.
34. Herskowitz A, Baughman KL, Rose NR, Neumann DA, Beschorner WE. Induction of major histocompatibility antigens on myocardial cells in patients with active myocarditis and idiopathic cardiomyopathy. In: Schulyheis HP, ed. New Concepts in Viral Heart Disease. Berlin, Germany: Springer-Verlag: 1988:312-324.
35. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol. 1994;23:46-53.
36. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeka J. Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the beta 1-adrenoreceptor with positive chronotropic effect. Circulation. 1994;89:2760-2767.
37. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 1992;85:1734-1742.
38. Sanderson JE, Koech D, Iha D, Ojiambo HP. T-Lymphocyte subsets in idiopathic dilated cardiomyopathy. Am J Cardiol. 1985;55:755-758.
39. Lowry PJ, Thompson RA, Littler WA. Cellular immunity in congestive cardiomyopathy: the normal cellular immune response. Br Heart J. 1985; 53:394-399.
40. Itagaki T, Yamakawa K, Ono S, Yoshinaga T, Umemoto S, Fukuta S, Kusukawa R. Dilated cardiomyopathy associated with natural killer cell deficiency. Am Heart J. 1988;115:1326-1328.
41. Lowry PJ, Gammage MD, Gentle TA, Baynham MI, Thompson RA, Littler WA. Suppressor T lymphocyte function in patients with idiopathic congestive cardiomyopathy. Br Heart J. 1987;57:458-461.